Bunyavirus outbreaks surge in Europe as health authorities ramp up defenses

Bunyavirus infections pose a growing health concern across multiple continents. These viruses, spread by arthropods like ticks and mosquitoes, can lead to illnesses ranging from mild to fatal. Recent outbreaks in Europe—particularly in Spain, Turkey, and Greece—have prompted stronger monitoring and prevention efforts by health authorities.

The Bunyaviridae family includes over 350 virus species, some of which cause severe diseases in humans. Among the most well-known are Hantavirus, Rift Valley Fever Virus, Crimean-Congo Haemorrhagic Fever Virus (CCHF), and La Crosse Virus. Transmission usually occurs through the bite of an infected insect, but contact with contaminated animals or materials can also spread the disease.

Symptoms vary depending on the virus and infection severity. Common signs include fever, fatigue, rash, nausea, and vomiting. In severe cases, complications can become life-threatening without prompt treatment. Between 2021 and 2026, Europe saw repeated CCHF outbreaks in specific regions. Spain, especially Castile and León, reported cases in 2021, 2023, and 2025. Turkey experienced annual infections in areas like the Kelkit Valley, while northern Greece recorded sporadic cases. In response, national health agencies—supported by the ECDC and WHO—implemented measures such as tick control with acaricides, contact tracing, quarantines, and public awareness campaigns on protective clothing and insect repellents. Currently, no vaccine or cure exists for bunyavirus infections. However, early diagnosis and supportive treatments can reduce complications and lower mortality risks. Certain groups, such as outdoor workers or residents in high-risk areas, face greater exposure due to their occupation or location.

Bunyaviruses remain a global health challenge, with outbreaks occurring in Africa, Asia, Europe, and the Americas. While prevention relies on vector control and public education, timely medical intervention remains essential. Health authorities continue to monitor and respond to new cases as they emerge.